2021
Movva N , Suh M , Jiang X , Reichert H , Bylsma L , Rizzo CP, White M, Fryzek J, Nelson CB. Medicaid infants have the highest respiratory syncytial virus (RSV) hospitalization burden and rates among United States (US) infants aged <1 year: An analysis of the 2011–2018 National (Nationwide) Inpatient Sample (NIS). Presentation to AAP Experience, National Conference & Exhibition (American Academy of Pediatrics), Philadelphia, PA, October 2021.
View Abstract
Publication: Abstracts and Presentations
Haddadin Z, Rankin DA, Lipworth L, Suh M , McHenry R, Blozinski A, Salib George S, Fernandez KN, Varjabedian R, Spieker AJ, Shepard DS, Halasa NB. 2021. Respiratory virus surveillance in infants across different clinical settings. J Pediat 234(July):p164-p171; doi: 10.1016/j.jpeds.2021.03.036 .
View Abstract
Publication: Manuscripts
2020
Fergie J, Gonzales T, Suh M , Jiang X , Fryzek J, Howard A, Bloomfield A. Medically attended respiratory syncytial virus hospitalizations (RSVH) and all-cause bronchiolitis hospitalizations (BH) among children aged ≤24 months at RSV season start with higher-risk congenital heart disease (CHD) before and after the 2014 American Academy of Pediatrics (AAP) policy. Presentation to IDWeek Conference on Infectious Disease, Virtual, October 2020.
Publication: Abstracts and Presentations
2016
Wikoff D , Borghoff S , Rager J, Harvey S , Haws L . 2016. A systematic review of the mechanistic evidence of tetrabromobisphenol TBBPA as a human carcinogen according to the ten key characteristics of carcinogens (TKCC) identified by Smith et al. (2016). PROSPERO 2016:CRD42016046429 .
View Abstract
Publication: Protocol Registrations
2012
Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lilycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM . 2012. Predicting later-life outcomes of early-life exposures. Environ Health Perspect 120:1353–1361; doi: 10.1289/ehp.1204934 .
View Abstract